These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Autologous peripheral blood stem cell transplantation after high dose therapy in patients with advanced lymphomas. Brice P, Marolleau JP, Dombret H, Lepage E, Baruchel A, Adam M, Miclea JM, Sitthy X, Gisselbrecht C. Bone Marrow Transplant; 1992 May; 9(5):337-42. PubMed ID: 1352162 [Abstract] [Full Text] [Related]
8. Tandem transplant of peripheral blood stem cells for patients with poor-prognosis Hodgkins's disease or non-Hodgkin's lymphoma. Fitoussi O, Simon D, Brice P, Makke J, Scrobohaci ML, Bibi Triki T, Hennequin C, Fermé C, Gisselbrecht C. Bone Marrow Transplant; 1999 Oct; 24(7):747-55. PubMed ID: 10516678 [Abstract] [Full Text] [Related]
20. A mononuclear cell dose of 3 x 10(8)/kg predicts early multilineage recovery in patients with malignant lymphoma treated with carmustine, etoposide, Ara-C and melphalan (BEAM) and peripheral blood progenitor cell transplantation. Smith RJ, Sweetenham JW. Exp Hematol; 1995 Dec 15; 23(14):1581-8. PubMed ID: 8542950 [Abstract] [Full Text] [Related] Page: [Next] [New Search]